Triethylamine hydrochloride → HCID 178504666, compound

HRID 460693Notes

Reaction equation

HRID 460693 reaction equation
[CH:1]1([C:7]2[N:12]3[N:13]=[CH:14][C:15]([C:16]#[N:17])=[C:11]3[N:10]=[CH:9][C:8]=2[C:18]2[CH:23]=[CH:22][C:21]([C:24]3[CH:29]=[CH:28][C:27]([S:30]([CH3:33])(=[O:32])=[O:31])=[CH:26][CH:25]=3)=[CH:20][CH:19]=2)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.Cl.C(N(CC)CC)C.[N-:42]=[N+:43]=[N-:44].[Na+]>C1(C)C=CC=CC=1.CN(C)C=O>[CH:1]1([C:7]2[N:12]3[N:13]=[CH:14][C:15]([C:16]4[NH:44][N:43]=[N:42][N:17]=4)=[C:11]3[N:10]=[CH:9][C:8]=2[C:18]2[CH:23]=[CH:22][C:21]([C:24]3[CH:25]=[CH:26][C:27]([S:30]([CH3:33])(=[O:31])=[O:32])=[CH:28][CH:29]=3)=[CH:20][CH:19]=2)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6]1

Participants

6

Reactant 3

HCID 11130Triethylamine hydrochloride2×HCID 33557Sodium Azide2×HCID 18445886HCID 18445886, compound

Product 1

HCID 178504666HCID 178504666, compoundYield 15.2%

Reagents, catalysts & solvents 2

HCID 1140TolueneSolventHCID 6228DimethylformamideSolvent

Procedure

To a solution of 42 mg (0.092 mmol) of 7-cyclohexyl-6-(4′-methanesulfonyl-biphenyl-4-yl)-pyrazolo[1,5-a]pyrimidine-3-carbonitrile in 1 mL of toluene and 1.2 mL of dimethylformamide (DMF) was added 76 mg (0.55 mmol) of triethylamine hydrochloride (Et3N—HCl), and 36 mg (0.55 mmol) of sodium azide and the resulting heterogeneous mixture was heated at 120° C. for 72 h, during which time 76 mg (0.55 mmol) of triethylamine hydrochloride (Et3N—HCl), and 36 mg (0.55 mmol) of sodium azide was added to the reaction mixture after every 24 h. The mixture was then cooled to rt, filtered and concentrated to a residue which was purified via reverse-phase chromatography to afford (after lyophilization) 7 mg (15% yield) of 7-cyclohexyl-6-(4′-methanesulfonyl-biphenyl-4-yl)-3-(1H-tetrazol-5-yl)-pyrazolo[1,5-a]pyrimidine as a white solid (90% purity, entry 443) as indicated by 1H-NMR; LC-MS calcd for C26H25N7O2S [M++H]+ 500.18; found 500.2.

Workup

  1. additionwas added to the reaction mixture after every 24 h
  2. filtrationfiltered
  3. concentrationconcentrated to a residue which
  4. customwas purified via reverse-phase chromatography

Sources & evidence

ORD record
ord-874f148c73d741e79f65c28b393b442c
Source dataset
uspto-grants-2007_03
Patent number
US07196111B2

Reaction notes

Loading…